“The strong immunoassay capabilities at BioAgilytix combined with the rapid assay development capabilities of Gyrolab workstation will enable us to more quickly provide our customers with the high quality results that they have come to expect.”
BioAgilytix Labs provides bioanalytical testing services focused on large molecules bioanalysis. BioAgilytix prides itself on having highly focused and experienced staff who offer clients comprehensive support in a consultative manner. As a state-of-the art immunoassay lab, they clearly felt the need to include the Gyrolab system in their suite of technology platforms.
Dr. Afshin Safavi, Founder and Chief Scientific Officer explains, “The strong immunoassay capabilities at BioAgilytix combined with the rapid assay development capabilities of Gyrolab workstation will enable us to more quickly provide our customers with the high quality results that they have come to expect.”
“The demand for Gyros technology is increasing rapidly so acquiring Gyrolab makes very good business sense. There are also clear scientific advantages. The ability to handle small samples is tremendously valuable in pediatrics and for small-volume samples such as spinal fluid. Added to that, the ability to run PK studies in single animals is extremely attractive in the pre-clinical arena.”
With every pharma and biotech company being asked to do more with less, outsourcing is on the increase. In this competitive environment, Gyrolab system offers clear operative advantages. “The system is automated, but also open. We can develop robust assays based on our own reagents or custom assays with our client’s reagents. These automated assays can be easily transferred between labs and sites, which is a major advantage with so many large molecule biotherapeutics in different phases of development.”
Dr. Safavi also sees the fast turnaround time afforded by Gyrolab system as a significant benefit. “As long as the courier is on time, you can deliver results in 24 hours. This minimizes the risk that patients are locked into clinical trials unnecessarily, and can allow data driven decisions by clinical teams.”
BioAgilytix greatly appreciates their relationship with Gyros. Dr. Safavi knows many of the Gyros staff personally. “They have come from pharma and CROs and fully understand the challenges involved. The staff at Gyros are very scientifically driven and go beyond the call of duty to ensure that they are meeting the needs of BioAgilytix and our customers.”
BioAgilytix Labs present themselves:
BioAgilytix is a leading bioanalytical testing laboratory specializing in large-molecule bioanalysis. Located in North Carolina’s Research Triangle, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assays services supporting the development and release testing of biologics and small molecule therapeutics. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, spirit-of-GLP, or GLP, and product release testing under GMP.
Our team of highly experienced scientific and QA professionals ensures high quality science, sample and data integrity, and regulatory compliance through all phases of clinical development allowing BioAgilytix to become a trusted partner to 6 out of the top 10 global pharmaceutical and biotech companies.
Find out more at www.bioagilytix.com.